Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S39] Utilization of RWD for the Clinical Trial Design and New Drug Application

Session Chair(s)

Takashi  Moriya, PhD, MBA

Takashi Moriya, PhD, MBA

Director, VEO Vaccines Value Evidence and Outcomes, Japan MA

GlaxoSmithKline K.K., Japan

Regulators, industries, and academia have been very interested in how to use Real World Data (RWD) in clinical development. This session will introduce approaches to conducting effective clinical trials using RWD and/or Electronic Health Records (EHRs), and share common current efforts to resolve problems that presently remain for more efficient use of RWD. Database research using RWDs is also actively being considered in Japan. This session will also introduce new clinical trial models in Japan from the viewpoints of industry, government, and academia.


Takeharu  Yamanaka, PhD

Can We Use RWD for Regulatory Decision in Oncology Drug Development?

Takeharu Yamanaka, PhD

Yokohama City University, Japan

Professor, Department of Biostatics, School of Medicine

Tammy  Guld, MS

Connected And Enriched Health Data To Optimize Clinical Research Across The Drug Development Cycle

Tammy Guld, MS

Janssen Pharmaceuticals, United States

Clinical Innovation Global Team Lead

Kinue  Nishioka, PhD

PMDA’s Activities for Regulatory Utilization of Real World Data

Kinue Nishioka, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Review Director, Office of Advanced Evaluation with Electronic Data

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.